Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02188784 · ClinicalTrials.gov registry record · Phase 3
Oral Iron Repletion Effects On Oxygen Uptake in Heart Failure
A Phase 3 study, sponsored by Adrian Hernandez.
- Completed
- Registry status
- Phase 3
- Development phase
- 225
- Enrollment target
NCT02188784 is a Phase 3 study that has completed, run by Adrian Hernandez. The registered enrollment target is 225 participants.
The verdict
NCT02188784, a Phase 3 study, has completed, sponsored by Adrian Hernandez.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 225 participants
- Enrollment target
Study Summary
The purpose of this study is to determine if oral iron (Fe) polysaccharide is superior to oral placebo in improving functional capacity as measured by change in peak VO2 (oxygen uptake) by CPET (Cardiopulmonary Exercise Testing) , of a broad population of patients with HFrEF (Heart Failure with Reduced Ejection Fraction) and Fe deficiency at 16 weeks. Hypothesis: In a broad population of HFrEF patients with Fe deficiency, compared to oral placebo, therapy with oral Fe polysaccharide will be associated with improvement in functional capacity at 16 weeks as assessed by CPET.
Interventions
- DRUG Polysaccharide Iron Complex 150 mg
- DRUG Placebo (for Polysaccharide Iron Complex)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 225 participants |
| Start Date | 2014-09-03 |
| Est. Completion | 2016-04-06 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02188784
The ClinicalTrials.gov registry entry for NCT02188784 describes a study currently listed as completed, categorized as Phase 3. The registered enrollment target is 225 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Adrian Hernandez, which has 7 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Polysaccharide Iron Complex 150 mg is the first listed.
NCT02188784 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02188784 about?
NCT02188784 is a clinical study titled "Oral Iron Repletion Effects On Oxygen Uptake in Heart Failure". The purpose of this study is to determine if oral iron (Fe) polysaccharide is superior to oral placebo in improving functional capacity as measured by change in peak VO2 (oxygen uptake) by CPET (Cardiopulmonary Exercise Testing) , of a broad population of patients with HFrEF (Heart Failure with Redu...
What is the current status of trial NCT02188784?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 225 participants. The study started on 2014-09-03. Estimated completion is 2016-04-06.
What interventions are being tested in trial NCT02188784?
The interventions under investigation include: Polysaccharide Iron Complex 150 mg (DRUG), Placebo (for Polysaccharide Iron Complex) (DRUG).
Who is sponsoring clinical trial NCT02188784?
This trial is sponsored by Adrian Hernandez, which has 7 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.